-
A combination of disappointing data and urging by a panel of physicians against blockbuster cholesterol drug Vytorin dented two pharma giants, as the annual meeting of the American College of Cardiology (Washington) got under way in Chicago.
-
CHICAGO Growth in the cardiovascular device market has slowed recently as safety issues with first-generation drug-eluting stents (DES) have combined with controversy re-garding the benefits of interventional therapy, compared to medical treatment, to drive decreased utilization.
-
-
-
Looking at CAD through the PERISCOPE; Addressing Agitation and Aggression in Persons with Advanced Dementia; It Used To Be Easier To Treat Sinusitis; CAC: A kinder, Gentler Way to Predict Cardiovascular Risk; Was Mae West Right? CV Risk Reduction: Too Much of A Good Thing is Wonderful; Midlife Contraception
-
-
Patients like quality, satisfaction surveys; Cigna stops paying for 'avoidable' conditions; States participating in QI institute; More hospitals offering palliative care; AHRQ resource features 100 innovations and tools; NCQA to expand quality program
-
ThedaCare's Appleton (WI) Medical Center has cut its average length of stay by 20% and improved quality, safety, and patient satisfaction by transforming the way it provides care.
-
In the absence of any meaningful literature that identify the number of preventable hospital-associated infections (HAIs) that occur in the Untied States, the Society for Healthcare Epidemiology of America (SHEA) was asked by Congress's Committee on Oversight and Government Reform to provide such an estimate.
-
How do you engage the top leadership of your facility in the pursuit of quality improvement? This has been one of the greatest challenges for quality professionals and is now a key objective of the Institute for Healthcare Improvement's (IHI) "5 Million Lives" campaign.